Please login to the form below

Not currently logged in
Email:
Password:

Pfizer’s Emms takes up ABPI presidency

He succeeds MSD’s Deepak Khanna at the UK pharma industry body

Jonathan Emms, ABPIPfizer's UK managing director Jonathan Emms has taken up the role of president of the Association of the British Pharmaceutical Industry (ABPI).

Emms (pictured right) was elected to the position at the pharma industry body in December 2013 and will now serve for one year with the option of standing for re-election.

He takes over from MSD's Deepak Khanna who spent two years as president, working alongside CEO Stephen Whitehead to improve the image of the industry in the UK and represent its companies in issues such as the value-based pricing debate and the implementation of a new NHS commissioning system in England.

Emms is no stranger to these issues, having served on the ABPI board and taken part in the negotiations over the future of drug pricing in the UK.

He has not been afraid to criticise the outcomes of these discussions too, saying in November that the revised drug pricing scheme announced by the Department of Health was a “missed opportunity for British patients, the UK economy and industry”.

These concerns about access to new medicines were reiterated by Emms in a statement on what he hopes to achieve in his new role.

“High barriers to getting innovative medicines to patients and low and slow usage across the NHS means we risk falling behind our European neighbours. As president, I want to tackle the challenges head on and work together – industry, government and NHS – to make change happen.”

14th April 2014

From: Research, Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics